Arcutis Biotherapeutics, Inc.

US$25.55As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ARQTHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR 2.37%
Div yield —
ROE 14.88%
Biotechnology
Beta (5Y) 1.63
PE TTM 117.8
TSR TTM 0.95%
Mkt cap US$3.231B
ROIC 33.39%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$30
19.31%
45.10%
Hold 4|4|5|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.64
0.67
0.72
0.78
25.65%
23.59%
27.19%
25.19%
Revenue$M
339.5
343.0
341.8
335.5
(1.28%)
(2.99%)
(1.43%)
(3.49%)
Peers (US$3.231B)
Cap (US$)
PE
3.268B
—
Capital
TTM
5Y
10Y
Leveragex
0.493
0.041
0.033
EBIT/Intx
0.825
0.137
0.167
Own earn%
93.84
(1.14)
(5.89)
Sh yield%
35.77
6.60
9.59
Owners
Insiders/Inst%
11.70
51.12
Short interest%
5.82
SBC / revenue%
2.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
28–33
$1 testx
—
Incr. ROIC%
63